diphenylcyclopropenone has been researched along with Itching in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Funahashi, H; Haruta-Tsukamoto, A; Ishida, Y; Miyahara, Y; Nishimori, T | 1 |
| Fukazawa, Y; Kiguchi, N; Kishioka, S; Ko, MC; Nakamura, TY; Saika, A; Saika, F; Uta, D | 1 |
| Kanehisa, K; Koga, K; Kohro, Y; Shiratori-Hayashi, M; Takamori, K; Tozaki-Saitoh, H; Tsuda, M | 1 |
| Abedini, R; Ghandi, N; Mirshamsi, A; Nasimi, M; Seirafi, H; Shakoei, S | 1 |
| Baba, M; Durdu, M; Özcan, D; Seçkin, D | 1 |
| Dai, S; Ji, W; Li, M; Liang, J; Liu, J; Liu, Y | 1 |
| Ma, LQ; Peng, YZ; Shen, FY; Wang, B; Wang, ZR; Wen, W; Zhang, TT; Zhao, X | 1 |
| Arakawa, S; Fujiwara, S; Hatano, Y; Katagiri, K | 1 |
| Hamada, R; Ikeda, M; Kamijima, R; Kodama, H; Ohtsu, H; Seike, M | 1 |
9 other study(ies) available for diphenylcyclopropenone and Itching
| Article | Year |
|---|---|
Perampanel attenuates scratching behavior induced by acute or chronic pruritus in mice.
Topics: Animals; Behavior, Animal; Chloroquine; Cyclopropanes; Disease Models, Animal; Histamine; Hypodermoclysis; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Nitriles; Pruritus; Pyridones; Quinoxalines; Receptors, AMPA | 2020 |
Chemogenetic activation of central gastrin-releasing peptide-expressing neurons elicits itch-related scratching behavior in male and female mice.
Topics: Animals; Behavior, Animal; Clozapine; Cyclopropanes; Dermatitis, Contact; Female; Gastrin-Releasing Peptide; Haptens; Male; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Pruritus | 2021 |
Specific activation of inhibitory interneurons in the spinal dorsal horn suppresses repetitive scratching in mouse models of chronic itch.
Topics: Animals; Behavior, Animal; Clozapine; Cyclopropanes; Disease Models, Animal; GABAergic Neurons; Gene Knock-In Techniques; Genetic Engineering; Humans; Injections, Spinal; Interneurons; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pruritus; Receptor, Muscarinic M3; Spinal Cord Dorsal Horn; Treatment Outcome | 2017 |
Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Anthralin; Child; Cyclopropanes; Dermatologic Agents; Drug Therapy, Combination; Female; Hair; Humans; Immunologic Factors; Male; Middle Aged; Pruritus; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2019 |
Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Alopecia Areata; Anthralin; Apoptosis; CD4-CD8 Ratio; Child; Cyclopropanes; Cytokines; Drug Eruptions; Drug Evaluation; Drug Therapy, Combination; Female; Folliculitis; Follow-Up Studies; Humans; Hyperpigmentation; Immunotherapy; Male; Middle Aged; Pruritus; Retrospective Studies; Severity of Illness Index; T-Lymphocyte Subsets; Treatment Outcome; Young Adult | 2015 |
The effect of kinin B1 receptor on chronic itching sensitization.
Topics: Animals; Antipruritics; Behavior, Animal; Bradykinin; Cell Line; Cyclopropanes; Dermatitis, Allergic Contact; Disease Models, Animal; Gene Expression Regulation; Humans; Keratinocytes; Male; Mice; Mice, Inbred C57BL; Pruritus; Receptor, Bradykinin B1; Sensation | 2015 |
Potentiation of synaptic transmission in Rat anterior cingulate cortex by chronic itch.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Chronic Disease; Cyclopropanes; Disease Models, Animal; Excitatory Postsynaptic Potentials; Gyrus Cinguli; N-Methylaspartate; Neurons; Pruritus; Rats, Sprague-Dawley; Receptors, AMPA; Synaptic Transmission; Up-Regulation | 2016 |
Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata.
Topics: Adolescent; Adult; Aged; Alopecia Areata; Cohort Studies; Cyclopropanes; Dermatitis, Contact; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Male; Middle Aged; Prospective Studies; Pruritus; Risk Assessment; Severity of Illness Index; Terfenadine; Treatment Outcome | 2006 |
Neuronal conditions of spinal cord in dermatitis are improved by olopatadine.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cyclopropanes; Dermatitis, Contact; Dibenzoxepins; Dose-Response Relationship, Drug; Eczema; Female; Histamine H1 Antagonists; Immunohistochemistry; Mice; Mice, Inbred BALB C; Neurons; Olopatadine Hydrochloride; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Pruritus; Skin; Substance P | 2006 |